Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Case 21: - The menopause blues
Published online by Cambridge University Press: 03 April 2024
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Summary
What medication(s) has the most evidence in the treatment of both perimenopausal depression and vasomotor symptoms (VMS)?
Keywords
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 363 - 378Publisher: Cambridge University PressPrint publication year: 2024
References
Avis, NE, Brambilla, D, McKinlay, SM, et al. A longitudinal analysis of the association between menopause and depression results from the Massachusetts Women’s Health Study. Ann Epidemiol 1994; 4:214–20CrossRefGoogle ScholarPubMed
Chen, LC, Yang, AC, Su, TP, et al. Symptomatic menopausal transition and subsequent bipolar disorder among midlife women with major depression: a nationwide longitudinal study. Arch Womens Ment Health 2017; 20:463–8Google ScholarPubMed
Cohen, LS, Soares, CN, Joffe, H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med 2005; 118:93–7CrossRefGoogle ScholarPubMed
Davis, SR, Jane, F. Menopause, sex and perimenopause. Aust Fam Physician 2011; 40:274–8Google ScholarPubMed
Freedman, RR. Hot flashes: behavioral treatments, mechanisms, and relation to sleep. Am J Med 2005; 118 Suppl, 12B:124–30CrossRefGoogle ScholarPubMed
Geller, SE, Studee, L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Women’s Health (Larchmt) 2005;14:634–49CrossRefGoogle ScholarPubMed
Kingsberg, SA. Hypoactive Sexual Desire Disorder: understanding the impact on midlife women. Female Patient 2011; 36:1–4Google Scholar
Kroon, JS, Wohlfarth, TD, Dieleman, J, et al. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. Bipolar Disord 2013; 15:306–13CrossRefGoogle ScholarPubMed
Lee, JH, Lee, JE, Harsh, V, et al. Pharmacotherapy for sexual dysfunction in women. Curr Psychiatry Rep 2022; 24:99–109CrossRefGoogle ScholarPubMed
Marsh, WK, Templeton, A, Ketter, TA, et al. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report. J Psychiatr Res 2008; 42:247–51CrossRefGoogle ScholarPubMed
Pachman, DR, Jones, JM, Loprinzi, CL. Management of menopause-associated vasomotor symptoms: current treatment options, challenges and future directions. Int J Womens Health 2010; 2:123–35Google ScholarPubMed
Parish, SJ, Hahn, SR, Goldstein, SW, et al. The International Society for the Study of Women’s Sexual Health process of care for the identification of sexual concerns and problems in women. Mayo Clin Proc 2019; 94:842–56CrossRefGoogle Scholar
Perich, TA, Roberts, G, Frankland, A, et al. Clinical characteristics of women with reproductive cycle–associated bipolar disorder symptoms. Aust N Z J Psychiatry 2017; 51:161–7CrossRefGoogle ScholarPubMed
Saito, K, Cui, H. Emerging roles of estrogen-related receptors in the brain: potential interactions with estrogen signaling. Int J Mol Sci 2018; 19:1091CrossRefGoogle ScholarPubMed
Stahl, SM, Muntner, N. Depression in Women: Treating Symptoms throughout the Life Span. Cambridge: Cambridge University Press, 2021, 129–42Google Scholar
Stubbs, C, Mattingly, L, Crawford, SA, et al. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women: HHS public access summary of the issues. J Okla State Med Assoc 2017; 110:272–4Google ScholarPubMed